Vijaya Pattabiraman

Company: Bright Peak Therapeutics

Job title: Co-Founder & Chief Technology Officer

Seminars:

Creating Next-Generation Immunotherapeutics Using Novel Chemistry Platform Technologies 2:15 pm

Bright Peak Therapeutics is developing a portfolio of next-generation precision immunotherapies powered by novel chemistry technologies Introducing Bright Peak’s platform technologies for preparing next-generation immunocytokines. Chemical protein synthesis platform yields enhanced optimized cytokines as payloads that are then conjugated to ‘off-the-shelf’ antibodies using a unique chemical conjugation platform to access nextgeneration immunocytokines Discussing preclinical data…Read more

day: Scientific Program Day Two